Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$263.97 - $344.64 $26,397 - $34,464
100 Added 5.56%
1,900 $635,000
Q2 2024

Aug 14, 2024

BUY
$268.26 - $339.48 $160,956 - $203,688
600 Added 50.0%
1,800 $491,000
Q1 2024

May 15, 2024

BUY
$304.11 - $351.99 $364,932 - $422,388
1,200 New
1,200 $415,000
Q3 2023

Nov 15, 2023

BUY
$350.25 - $422.63 $280,200 - $338,104
800 New
800 $286,000
Q1 2023

May 15, 2023

BUY
$418.69 - $503.0 $41,869 - $50,300
100 Added 12.5%
900 $425,000
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $281,368 - $364,808
800 New
800 $336,000
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $637,956 - $715,212
-900 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $591,939 - $743,193
900 New
900 $674,000
Q2 2021

Aug 06, 2021

SELL
$576.64 - $649.04 $345,984 - $389,424
-600 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$547.01 - $662.35 $109,402 - $132,470
-200 Reduced 25.0%
600 $338,000
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $904,149 - $1.33 Million
-2,700 Reduced 77.14%
800 $346,000
Q1 2020

May 11, 2020

BUY
$320.01 - $409.07 $864,027 - $1.1 Million
2,700 Added 337.5%
3,500 $1.22 Million
Q4 2019

Feb 12, 2020

SELL
$319.73 - $374.2 $671,433 - $785,820
-2,100 Reduced 72.41%
800 $296,000
Q3 2019

Nov 14, 2019

BUY
$304.55 - $345.24 $487,280 - $552,384
1,600 Added 123.08%
2,900 $969,000
Q2 2019

Aug 20, 2019

SELL
$286.93 - $312.59 $717,325 - $781,474
-2,500 Reduced 65.79%
1,300 $406,000
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $650,470 - $920,489
2,900 Added 322.22%
3,800 $1.16 Million
Q3 2018

Nov 14, 2018

BUY
$289.28 - $326.15 $260,351 - $293,535
900 New
900 $282,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.